Antiviral Properties of Turmeric (Curcuma longa L.) in COVID-19 Prevention

Yuneka  Saristiana; Fendy Prasetyawan

Authors

Yuneka Saristiana Universitas Kadiri Author
Fendy Prasetyawan Universitas Kadiri Author

Keywords:

Curcuma longa (turmeric), curcumin, COVID-19

Abstract

Curcuma longa (turmeric) is a plant that has long been recognized in traditional medicine for its various health benefits. The primary active compound in turmeric, curcumin, possesses a range of biological properties, including antioxidant, anti-inflammatory, and antimicrobial effects. Moreover, recent studies have revealed that curcumin also has potential as an effective antiviral agent, particularly in the context of COVID-19 prevention. Curcumin has been shown to inhibit the activity of the main protease of SARS-CoV-2, the virus responsible for COVID-19, which is crucial for viral replication. Additionally, curcumin is capable of activating the Nrf2 pathway, which is a defense mechanism of the body against oxidative stress caused by respiratory viral infections. Based on these findings, Curcuma longa shows significant potential as a natural preventive agent against COVID-19, while also helping to reduce the severity of infection symptoms. The combination of its antiviral properties and broad therapeutic effects makes turmeric a promising candidate in supporting prevention and treatment efforts during the Covid-19 pandemic.

Downloads

Download data is not yet available.

References

Babaei, F., Nassiri-Asl, M., & Hosseinzadeh, H. (2020). Curcumin (a constituent of turmeric): New treatment option against COVID-19. Journal of Traditional and Complementary Medicine, 10(4), 395–397. https://doi.org/10.1016/j.jtcme.2020.06.013

Bormann, M., Alt, M., Schipper, L., van de Sand, L., Le-Trilling, V. T. K., Rink, L., Heinen, N., Madel, R. J., Otte, M., Wuensch, K., Heilingloh, C. S., Mueller, T., Dittmer, U., Elsner, C., Pfaender, S., Trilling, M., Witzke, O., & Krawczyk, A. (2021). Turmeric root and its bioactive ingredient curcumin effectively neutralize SARS-CoV-2 in vitro. Viruses, 13(10), 1914. https://doi.org/10.3390/v13101914

Fu, Y. S., Ho, W. Y., Kang, N., Tsai, M. J., Wu, J., Huang, L., & Weng, C. F. (2022). Pharmaceutical prospects of curcuminoids for the remedy of COVID-19: Truth or myth. Pharmaceuticals, 15(5), 631. https://doi.org/10.3390/ph15050631

Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: Lessons learned from clinical trials. The AAPS Journal, 15(1), 195–218. https://doi.org/10.1208/s12248-012-9432-8

Huang, Y. F., Bai, C., He, F., Xie, Y., & Zhou, H. (2020). Review on the potential action mechanisms of curcumin in COVID-19 infection. Pharmacological Reports, 72(6), 1346–1355. https://doi.org/10.1007/s43440-020-00139-w

Kumar, M., Sodhi, K. K., & Singh, D. K. (2021). Addressing the potential role of curcumin in the prevention of COVID-19 by targeting the Nsp9 replicase protein through molecular docking. Archives of Microbiology, 203, 1691–1696. https://doi.org/10.1007/s00203-021-02174-y

Marik, P. E. (2020). Vitamin C and corticosteroids in SARS-CoV-2 infection: A systematic review. Critical Care, 24, 502. https://doi.org/10.1186/s13054-020-03179-0

Mishra, S., & Sharma, S. (2021). Curcumin and COVID-19: A systematic review. Indian Journal of Clinical Biochemistry, 36(2), 264–271. https://doi.org/10.1007/s12291-021-00968-3

Prasad, S., & Tyagi, A. K. (2020). Curcumin and its analogues: A potential treatment for COVID-19. Drug Development Research, 81(7), 731–737. https://doi.org/10.1002/ddr.21756

Rajesh, K. T., Mudnakudu-Nagaraju, K. K., Shivamallu, C., Subramaniam, K. T., Radhakrishnan, A., Bhojraj, S., & Kuppusamy, G. (2021). Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon, 7(7), e06350. https://doi.org/10.1016/j.heliyon.2021.e06350

Rattis, B. A. C., Ramos, S. G., & Celes, M. R. N. (2021). Curcumin as a potential treatment for COVID-19. Frontiers in Pharmacology, 12, 659545. https://doi.org/10.3389/fphar.2021.659545

Saeedi-Boroujeni, A., & Mahmoudian-Sani, M. R. (2021). Anti-inflammatory potential of curcumin in COVID-19 disease: A narrative review. Journal of Complementary and Integrative Medicine, 18(2), 199–204. https://doi.org/10.1515/jcim-2020-0171

Sahin, K., Orhan, C., Akdemir, F., Tuzcu, M., Iben, C., Sahin, N., & Yilmaz, I. (2021). Curcumin and piperine supplementation reduced lung inflammation and histopathologic severity in a COVID-19 model. The Journal of Nutritional Biochemistry, 93, 108619. https://doi.org/10.1016/j.jnutbio.2021.108619

Salehi, B., Upadhyay, S., Erdogan-Orhan, I., Kumar, N. V. A., Martorell, M., López, M. D., & Sharifi-Rad, J. (2020). Therapeutic potential of curcumin in COVID-19 treatment: A narrative review. Journal of Cellular and Molecular Medicine, 24(16), 10218–10229. https://doi.org/10.1111/jcmm.15674

Singh, S., Parsa, V., & Kumar, A. (2021). Curcumin and its derivatives: Hope or hype in the treatment of COVID-19? Future Medicinal Chemistry, 13(3), 231–243. https://doi.org/10.4155/fmc-2020-0303

Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012). PAMPs and DAMPs: Signal 0s that spur autophagy and immunity. Immunological Reviews, 249(1), 158–175. https://doi.org/10.1111/j.1600-065X.2012.01146.x

Thimmulappa, R. K., Mudnakudu-Nagaraju, K. K., Shivamallu, C., & Kuppusamy, G. (2021). Immunomodulatory effects of curcumin in the prevention of viral infections. Frontiers in Pharmacology, 12, 659545. https://doi.org/10.3389/fphar.2021.659545

Zia, A., Bhardwaj, A., Srivastava, P., & Verma, M. (2022). Evaluating the efficacy of curcumin-based formulations against COVID-19: A review. Current Drug Delivery, 19(3), 245–255. https://doi.org/10.2174/1567201819666211030103855